Smolen, J. S., van Vollenhoven, R., Kavanaugh, A., Strand, V., Vencovsky, J., Schiff, M., . . . van der Heijde, D. (2015). Certolizumab pegol plus methotrexate 5-year results from the rheumatoid arthritis prevention of structural damage (RAPID) 2 randomized controlled trial and long-term extension in rheumatoid arthritis patients. Arthritis Res Ther.
Citação norma ChicagoSmolen, Josef S., et al. "Certolizumab Pegol Plus Methotrexate 5-year Results From the Rheumatoid Arthritis Prevention of Structural Damage (RAPID) 2 Randomized Controlled Trial and Long-term Extension in Rheumatoid Arthritis Patients." Arthritis Res Ther 2015.
ציטוט MLASmolen, Josef S., et al. "Certolizumab Pegol Plus Methotrexate 5-year Results From the Rheumatoid Arthritis Prevention of Structural Damage (RAPID) 2 Randomized Controlled Trial and Long-term Extension in Rheumatoid Arthritis Patients." Arthritis Res Ther 2015.